据主管机构称,莎拉波娃在1月26日未能通过药物检测,当时她刚在四分之一决赛中输给了赛雷纳·威廉姆斯。3月2日莎拉波娃受到违反反兴奋剂条令的指控。
There was much speculation that Sharapova's Monday briefing with reporters centered on retirement plans following an increasing number of injuries, but the failed test was a bigger bombshell. And it came in the wake of match-fixing allegations that rocked tennis in Melbourne.
很多人猜测随着莎拉波娃身体损伤的增加,她在周一的资讯发布会内容将以自己的退休计划为中心,但是药检失败却是一个更大的爆炸性资讯。在假球指控发生后不久,这一消息再次轰动了墨尔本网球界。
"A few days ago I received a letter from the (International Tennis Federation) that I failed a drug test at the Australian Open," the five-time grand slam winner said in the press conference that was streamed live on Sharapova's website. "I did fail the test and take full responsibility for it.
五次大满贯得主莎拉波娃在资讯发布会上表示:“几天前,我收到了一封来自国际网球联合会的信件,信中说,我在澳大利亚网球公开赛的药检没有通过。”莎拉波娃的官网直播了这场资讯发布会。“我的确药检失败,我会负全部责任。”
"For the past 10 years I have been given a medicine called mildronate by my doctor, my family doctor, and a few days ago after I received the ITF letter I found out that it also has another name, meldonium, which I did not know.
【网坛美女莎拉波娃药检没过关遭禁赛】相关文章:
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15